Упрощенная HTML-версия
289.
How to assess sympathetic activity in humans / G. Grassi [et al.] // J
Hypertens. – 1999. – Vol. 17. – P. 719-734.
290.
Huang P. L. A comprehensive definition for metabolic syndrome / P. L. Huang
// Dis. Model. Mech. – 2009. – Vol. 2, № 5 – 6. P. 231 – 237.
291.
Hyperinsulinemia, hyperglycemia, and impaired hemostasis / J. B. Meigs [et
al.] // JAMA. – 2000. – Vol. 283. – P. 221–228.
292.
Hypertension and insulin resistance: role of sympathetic nervous system
activity / M. A. Supiano [et al.] // Am. J. Physiol. – 1992. – Vol. 263. – P. 935-
942.
293.
Hypertension and the prothrombotic state / S. Nadar [et al.] // J. Am. Coll.
Cardiol. – 2003. – Vol. 41. – P. 1847.
294.
Hypertensive coronary microcirculation - effects of the imidazoline-receptor-
agonist moxonidine / W. Motz [et al.] // Cardiovasc Risk Factors. – 1995. –
Vol. 5. – P. 28-32.
295.
Iadecola C. Hypertension and cerebrovascular dysfunction / C. Iadecola, R. L.
Davisson // Cell. Metab. – 2008. – Vol. 7, № 6. – P. 476 – 484.
296.
Iadecola С. Threats to the mind: aging, amyloid, and hypertension / C.
Iadecola, L. Park, C. Capone // Stroke. – 2009. – Vol. 40, Suppl. 3. – P. 40-44.
297.
Imidazole receptors and clonidine-displacing substance in relationship to
control of blood pressure, neuroprotection, and adrenomedullary secretion /
D.J. Reis [et al.] // Am. J. Hypertens. – 1992. – Vol. 5. – P. 51-57.
298.
Imidazoline receptors. A new concept in central regulation of the arterial blood
pressure / P. Bousquet [et al.] // Am. J. Hypertens . – 1992. – Vol. 5. – P. 47-
50.
299.
Impact of high-intensity exercise on energy expenditure, lipid oxidation and
body fatness / M. Yoshioka [et al.] // Int. J. Obes. – 2001. – Vol. 25. – P. 332–
339.